Freedom Care Group Holdings Ltd.

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, RHC.AX has a market cap of 9B. Regarding current trading prices, FCG.AX is priced at A$0.04, while RHC.AX trades at A$39.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas RHC.AX's P/E ratio is 30.96. In terms of profitability, FCG.AX's ROE is +0.31%, compared to RHC.AX's ROE of +0.06%. Regarding short-term risk, FCG.AX is more volatile compared to RHC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check RHC.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, REG.AX has a market cap of 1.9B. Regarding current trading prices, FCG.AX is priced at A$0.04, while REG.AX trades at A$6.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas REG.AX's P/E ratio is 51.33. In terms of profitability, FCG.AX's ROE is +0.31%, compared to REG.AX's ROE of -1.63%. Regarding short-term risk, FCG.AX is more volatile compared to REG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check REG.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, SNZ.AX has a market cap of 1.8B. Regarding current trading prices, FCG.AX is priced at A$0.04, while SNZ.AX trades at A$7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas SNZ.AX's P/E ratio is 8.33. In terms of profitability, FCG.AX's ROE is +0.31%, compared to SNZ.AX's ROE of +0.08%. Regarding short-term risk, FCG.AX is more volatile compared to SNZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check SNZ.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, RYM.AX has a market cap of 1.7B. Regarding current trading prices, FCG.AX is priced at A$0.04, while RYM.AX trades at A$1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas RYM.AX's P/E ratio is -4.72. In terms of profitability, FCG.AX's ROE is +0.31%, compared to RYM.AX's ROE of -0.10%. Regarding short-term risk, FCG.AX is more volatile compared to RYM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check RYM.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, EHE.AX has a market cap of 547.7M. Regarding current trading prices, FCG.AX is priced at A$0.04, while EHE.AX trades at A$3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas EHE.AX's P/E ratio is -23.69. In terms of profitability, FCG.AX's ROE is +0.31%, compared to EHE.AX's ROE of -0.07%. Regarding short-term risk, FCG.AX is more volatile compared to EHE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check EHE.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, OCA.AX has a market cap of 470.8M. Regarding current trading prices, FCG.AX is priced at A$0.04, while OCA.AX trades at A$0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas OCA.AX's P/E ratio is 10.83. In terms of profitability, FCG.AX's ROE is +0.31%, compared to OCA.AX's ROE of +0.04%. Regarding short-term risk, FCG.AX is more volatile compared to OCA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check OCA.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, CAJ.AX has a market cap of 413.1M. Regarding current trading prices, FCG.AX is priced at A$0.04, while CAJ.AX trades at A$0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas CAJ.AX's P/E ratio is -38.50. In terms of profitability, FCG.AX's ROE is +0.31%, compared to CAJ.AX's ROE of -0.12%. Regarding short-term risk, FCG.AX is more volatile compared to CAJ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check CAJ.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, PSQ.AX has a market cap of 352.3M. Regarding current trading prices, FCG.AX is priced at A$0.04, while PSQ.AX trades at A$2.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas PSQ.AX's P/E ratio is 218.00. In terms of profitability, FCG.AX's ROE is +0.31%, compared to PSQ.AX's ROE of +0.03%. Regarding short-term risk, FCG.AX is more volatile compared to PSQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check PSQ.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, HLA.AX has a market cap of 173.8M. Regarding current trading prices, FCG.AX is priced at A$0.04, while HLA.AX trades at A$1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas HLA.AX's P/E ratio is 35.90. In terms of profitability, FCG.AX's ROE is +0.31%, compared to HLA.AX's ROE of +0.04%. Regarding short-term risk, FCG.AX is more volatile compared to HLA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check HLA.AX's competition here

FCG.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FCG.AX stands at 4M. In comparison, AJJ.AX has a market cap of 14.5M. Regarding current trading prices, FCG.AX is priced at A$0.04, while AJJ.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FCG.AX currently has a P/E ratio of 3.70, whereas AJJ.AX's P/E ratio is -1.90. In terms of profitability, FCG.AX's ROE is +0.31%, compared to AJJ.AX's ROE of -0.15%. Regarding short-term risk, FCG.AX is more volatile compared to AJJ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FCG.AX.Check AJJ.AX's competition here